Literature DB >> 7246270

An alternate-day corticosteroid regimen in maintenance therapy of giant cell arteritis.

B A Bengtsson, B E Malmvall.   

Abstract

It is well established that the side-effects of corticosteroid treatment can be reduced by administering the steroid on alternate days. Twenty-seven patients with giant cell arteritis were given daily treatment initially, followed by a gradual transition to alternate-day treatment. It was possible to maintain 18 (67%) of 27 patients on this regimen. In 9 (33%) the regimen was abandoned because of clinical symptoms on the "day off". These patient, however, could be maintained with a single morning dose of the corticosteroid. Morning plasma cortisol levels on the treatment day were normal in all patients treated with 20 mg prednisolone or less every other day.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7246270     DOI: 10.1111/j.0954-6820.1981.tb11605.x

Source DB:  PubMed          Journal:  Acta Med Scand        ISSN: 0001-6101


  2 in total

1.  Prednisolone combined with adjunctive immunosuppression is not superior to prednisolone alone in terms of efficacy and safety in giant cell arteritis: meta-analysis.

Authors:  M Yates; Y K Loke; R A Watts; A J MacGregor
Journal:  Clin Rheumatol       Date:  2013-09-12       Impact factor: 2.980

Review 2.  Giant cell arteritis. Epidemiology and treatment.

Authors:  E Nordborg; R Andersson; B A Bengtsson
Journal:  Drugs Aging       Date:  1994-02       Impact factor: 3.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.